← Back to Search

Educational Intervention for Early-Stage Cancer Care Coordination

N/A
Recruiting
Research Sponsored by University of Vermont Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trial will study how educating rural cancer patients on self-advocacy and care coordination can improve their perception of care.

Who is the study for?
This trial is for adults over 18 living in rural Vermont with early-stage (I, II, or III) breast, lung, or colon cancer who are about to start or have just started adjuvant chemotherapy. They must understand English and cannot have had chemotherapy for another cancer within the last three years.Check my eligibility
What is being tested?
The study tests a video educational tool designed to improve understanding of cancer care coordination and self-advocacy among patients. Participants will be randomly assigned to receive this intervention either at the beginning of their therapy or after four months.See study design
What are the potential side effects?
Since this is an educational intervention rather than a medical treatment, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Care Coordination Instrument Score
Secondary outcome measures
Cancer Knowledge
Satisfaction with Educational Videos
Self-Advocacy Score

Trial Design

2Treatment groups
Experimental Treatment
Group I: Upfront Educational InterventionExperimental Treatment1 Intervention
Participants will receive a video-based intervention after completing baseline survey instruments and prior to retesting after 4-6 months.
Group II: Delayed Educational InterventionExperimental Treatment1 Intervention
Participants will complete baseline survey instruments and again complete surveys after 4-6 months. They will then receive the video-based educational tablet.

Find a Location

Who is running the clinical trial?

University of Vermont Medical CenterLead Sponsor
41 Previous Clinical Trials
25,785 Total Patients Enrolled

Media Library

Cancer Research Study Groups: Delayed Educational Intervention, Upfront Educational Intervention
Cancer Clinical Trial 2023: Table-based Educational Intervention Highlights & Side Effects. Trial Name: NCT05723250 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this study still available to interested parties?

"Data published on clinicaltrials.gov indicates that the trial is presently recruiting participants - with an initial posting date of March 16th, 2023 and a recent update from March 1st, 2023."

Answered by AI

To what extent are participants being treated within the scope of this research?

"Affirmative. The clinicaltrials.gov platform confirms that this trial, initially posted on March 16th 2023, still requires additional participants and has recently been updated (March 1st). 40 patients are being sought at a single location."

Answered by AI

What are the core goals of this research?

"The principal objective of this study, to be measured over a Baseline and 4 month interval, is the Care Coordination Instrument Score at both points in time. Other metrics include Satisfaction with Educational Videos (a 5-item questionnaire), Self-Advocacy Score (calculated by summing 20 items on a Likert scale from 1 to 6) and Cancer Knowledge Questionnaire results."

Answered by AI
~12 spots leftby Sep 2024